Twist Bioscience Reports First Quarter Fiscal 2020 Financial Results
Retrieved on:
Thursday, February 6, 2020
Orders: Total orders received for the first quarter of fiscal 2020 were $24.8 million, compared to $15.2 million for the same period of fiscal 2019.
Key Points:
- Orders: Total orders received for the first quarter of fiscal 2020 were $24.8 million, compared to $15.2 million for the same period of fiscal 2019.
- Revenue: Total revenues were $17.2 million for the first quarter of fiscal 2020 compared to $11.5 million for the same period of fiscal 2019.
- Cost of Revenues: Cost of revenues for the first quarter of fiscal 2020 was $13.8 million compared to $11.9 million for the same period of fiscal 2019.
- Research and Development Expenses: Research and development expenses for the first quarter of fiscal 2020 were $10.3 million compared to $7.3 million for the same period of fiscal 2019.